跳至主要内容
临床试验/KCT0006995
KCT0006995尚未招募未知

Glycosylated hemoglobin is a predictive factor for response of radical radiotherapy in patients with limited-stage small cell lung cancer

Kyung Hee University Hospital0 个研究点目标入组 356 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
356

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • Histologically proven small cell lung cancer
  • - Limited stage according to AJCC
  • - ECOG performance status =2
  • - Follow-up duration =1 year
  • - HbA1c levels were checked 2 week before the start of radiotherapy

排除标准

  • - Histologically proven non-small cell lung cancer
  • - Patients who did not complete the planned radiotherapy
  • - No available follow-up data

研究者

发起方
Kyung Hee University Hospital

相似试验